Faustino Mollinedo

Faustino Mollinedo

Professor, CIB, Consejo Superior de Investigaciones Científicas, Madrid, Spain
Verified email at cib.csic.es
Cited by 17296
Cell death Anticancer drugs Neutrophils Antileishmanial drugs Drug mechanism of action
Ines Batinic-Haberle

Ines Batinic-Haberle

Professor of Radiation Oncology, Duke University School of Medicine
Verified email at duke.edu
Cited by 15676
Bioinorganic chemistry tumor biology drug development drug mechanism of action
Peter Tonge

Peter Tonge

Stony Brook University
Verified email at stonybrook.edu
Cited by 8607
Chemical biology ultrafast spectroscopy enzyme inhibitor design drug mechanism of action
luis rivas

luis rivas

Centro de Investigaciones Biológicas (CSIC) Madrid
Verified email at cib.csic.es
Cited by 4950
Leishmania antimicrobial peptide metabolism bioenergetics drug mechanism of action
Michael Riscoe

Michael Riscoe

Research Career Scientist, Portland VA Medical Center and Professor, Dept. of Mol …
Verified email at ohsu.edu
Cited by 4581
Malaria Chemotherapy Drug Design and Discovery Drug Mechanism of Action Drug Resistance
Lauren Surface

Lauren Surface

Massachusetts General Hospital, Harvard Medical School
Verified email at mgh.harvard.edu
Cited by 1058
Bone homeostasis drug mechanism of action
Connie Diakos

Connie Diakos

University of Sydney
Verified email at sydney.edu.au
Cited by 987
cancer inflammation drug mechanism of action
Quinlan Sievers, MD PhD

Quinlan Sievers, MD PhD

UCSF Internal Medicine
Verified email at ucsf.edu
Cited by 45
Drug Mechanism of Action Ubiquitin Ligase Biology Hematologic Maligancies